IRCT138706211241N1已完成2 期
Comparison of Sequential therapy with standard therapy for eradication of H.Pylori infection in uremic patients
Mazandaran University of Medical Sciences and Health Services0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 70 years（—）
- 性别
- All
入选标准
- •age more than 18 years, dyspepsia during last month and positive H.pylori infection (positive rapid urease test and positive biopsy by endoscope).
- •Exclusion criteria: Antibiotic therapy for eradication of H.pylori, consumption of Proton Pump Inhibitor, H2 blockers, Bismuth, or NSAIDS during last month, consumption of anticoagulants, Ketoconazol or corticosteroids, history of gastric or esophageal surgery, hypersensitivity to antibiotics, negative biopsy of GI, smoking or alcohol use, pregnancy, lactation, severe heart diseases (MI, EF = 30), liver & thyroid diseases and malignancy.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Drug therapy of Helicobacter pylori infectioHelicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2017062234698N1Qazvin University of Medical Sciences120
已完成
2 期
Efficacy of sequential therapy in eradication of Helicobacter PyloriCondition 1: Dyspepsia. Condition 2: Helicobacter pylori.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersDyspepsiaIRCT2015082323736N1Vice chancellor for research, Lorestan University of Medical Sciences300
已完成
2 期
Investigating the effect of Sequential Therapy and Triple Therapy for H-pylori treatmentIRCT20180131038581N2Bandare-abbas University of Medical Sciences144
已完成
3 期
A comparative study of sequential therapy and 10-day standard triple therapy for Helicobacter pylori infectioEradication of Helicobacter pylori infectionOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Other infectious diseasesACTRN12613000377730Sanren Lin280
已完成
不适用
Randomized comparison of Sequential therapies with Sunitinib and Sorafenib in Advanced Renal Cell Carcinomarenal cell cancerJPRN-UMIN000003040Yamagata University Faculty of Medicine120